American Well Corporation AMWL
Analyst Ratings
- Consensus
- Hold — 1 Buy · 5 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $9.50 (-29.2% downside)
Key Stats
- Today's Range
- $13.36 – $13.96
- 50-Day Range
- $9.90 – $14.19
- 52-Week Range
- $3.71 – $14.19
- Volume
- 83K shs
- Average Volume
- 98K shs
- Market Cap
- $233.87 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.00
- Price / Sales
- 1.07
Short Interest
- Short Interest
- 28.46%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $218.53 million
- Net Income
- $-77,006,000
- Net Margin
- -35.24%
- Return on Equity
- -32.87%
- Debt-to-Equity
- —
About American Well Corporation
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
Related Stocks
Compare head-to-head: AMWL vs V·AMWL vs MA·AMWL vs UBER·AMWL vs ACN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.